|
Originally published In Press as doi:10.1074/jbc.M600178200 on January 31, 2006
J. Biol. Chem., Vol. 281, Issue 15, 10127-10133, April 14, 2006
Endogenous Lipid Hydroperoxide-mediated DNA-adduct Formation in Min Mice*
Michelle V. Williams,
Seon Hwa Lee,
Michael Pollack, and
Ian A. Blair1
From the
Center for Cancer Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160
Despite intensive research over the last two decades, there are still no specific markers of endogenous lipid hydroperoxide-mediated DNA damage. We recently demonstrated that heptanone-etheno-2'-deoxyguanosine adducts are formed in the DNA of rat intestinal epithelial cells that stably express cyclooxygenase-2. Heptanone-etheno adducts can only arise from the reaction of lipid hydroperoxide-derived 4-oxo-2(E)-nonenal with DNA. This raised the possibility that similar adducts would be formed in vivo in settings where cyclooxygenase-2 expression is increased. Therefore, DNA-adduct formation was studied in C57BL/6JAPCmin mice, a colorectal cancer mouse model in which cyclooxygenase-2 is up-regulated. 15(S)-Hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid is the major lipid hydroperoxide produced endogenously by cyclooxygenase-2. It undergoes homolytic decomposition to the DNA-reactive bifunctional electrophile 4-oxo-2(E)-nonenal, which forms heptanone-etheno adducts with DNA. A quantitative comparison was made of the heptanone-etheno-DNA adducts present in C57BL/6J and C57BL/6JAPCmin mice. Using highly specific and sensitive methodology based on stable isotope dilution liquid chromatography/tandem mass spectrometry, we have detected the endogenous formation of heptanone-etheno adducts in mammalian tissue DNA for the first time. In addition, we found that there were statistically significant increased levels of the heptanone-etheno-2'-deoxyguanosine and heptanone-etheno-2'-deoxycytidine adducts in the C57BL/6JAPCmin mice when compared with the control C57BL/6J mice.
Received for publication, January 9, 2006
* This work was supported by National Institutes of Health Grant RO1CA 91016. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental material.
1 To whom correspondence should be addressed: Center for Cancer Pharmacology, 854 BRB II/III, 421 Curie Blvd., University of Pennsylvania, Philadelphia PA 19104-6160. Tel.: 215-573-9880; Fax: 215-573-9889; E-mail: ian{at}spirit.gcrc.upenn.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I.-Y. Yang, K. Hashimoto, N. de Wind, I. A. Blair, and M. Moriya
Two Distinct Translesion Synthesis Pathways across a Lipid Peroxidation-derived DNA Adduct in Mammalian Cells
J. Biol. Chem.,
January 2, 2009;
284(1):
191 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Blair
DNA Adducts with Lipid Peroxidation Products
J. Biol. Chem.,
June 6, 2008;
283(23):
15545 - 15549.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pang, X. Zhou, H. Yu, M. Dong, K. Taghizadeh, J. S. Wishnok, S. R. Tannenbaum, and P. C. Dedon
Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation
Carcinogenesis,
August 1, 2007;
28(8):
1807 - 1813.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|